Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Yonsei med. j ; Yonsei med. j;: 207-214, 1991.
Article in English | WPRIM | ID: wpr-151500

ABSTRACT

A molecularly cloned human cellular H-ras (c-H-ras) oncogene(pbc N1 plasmid) was treated with N-acetoxyacetylaminofluorene (AAAF) in vitro and subcloned into E.coli. This was done to identify the mutational changes at specific codons of the gene. Guanine nucleotides were identified as the major AAAF binding site of the DNA adduct formed. Base changes in codons 12 and 61 were determined by the analysis of restriction fragment length polymorphism (RFLP) and site specific oligonucleotide hybridization. RFLP was observed due to the loss of the Hpall recognition site at codon 11 and 12 of AAAF-treated c-H-ras gene. Hybridization of AAAF treated c-H-ras with 32P-labeled oligonucleotide probes for the mutant alleles of codon 61 showed no substitutions at codon 61. From these results, it is assumed that AAAF treatment in vitro caused mutation at codon 12 but not at codon 61 of the c-H-ras oncogene and that codon 12 is the primary target of mutation by AAAF


Subject(s)
Humans , Acetoxyacetylaminofluorene/pharmacology , Chromatography, Thin Layer , Codon , DNA Damage , Electrophoresis, Agar Gel , Genes, ras/drug effects , Mutagenesis, Site-Directed , Oligonucleotide Probes , Plasmids/drug effects , Polymorphism, Restriction Fragment Length
SELECTION OF CITATIONS
SEARCH DETAIL